Annual report pursuant to Section 13 and 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS (Details Narrative)

v3.23.1
DERIVATIVE FINANCIAL INSTRUMENTS (Details Narrative)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Oct. 30, 2020
USD ($)
$ / shares
shares
Feb. 28, 2020
$ / shares
shares
Jan. 06, 2020
USD ($)
$ / shares
shares
Jan. 02, 2020
$ / shares
shares
May 18, 2018
USD ($)
shares
May 18, 2018
$ / shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Derivative liability | $ $ 22,554            
Amended and Restated Loan Agreement [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants to purchase common stock | shares             320,000  
Warrant exercise price | $ / shares               $ 0.10
Derivative liability | $             $ 30,012  
Warrant expiry date             May 11, 2021  
Loan Agreement [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants to purchase common stock | shares     5,000,000 200,000   5,000,000    
Warrant exercise price | (per share)     $ 0.05 $ 0.10   $ 0.10    
Warrant expiry date     Jan. 06, 2023 Mar. 01, 2022   Jan. 02, 2023    
Loan Agreement [Member] | Warrant [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Warrants to purchase common stock | shares     5,000,000   5,000,000      
Warrant exercise price | $ / shares     $ 0.10   $ 0.10      
Derivative liability | $     $ 95,352   $ 144,259